The insomnia treatment market is driven by several key factors, including the growing prevalence of sleep disorders, increasing awareness about the importance of sleep, and the availability of new and innovative treatments. As the global population ages, the prevalence of insomnia is expected to rise, driving demand for treatment options. Additionally, the growing adoption of non-pharmacological treatments, such as cognitive behavioral therapy for insomnia (CBT-I), is expected to create new opportunities for companies operating in the market. However, the market is also characterized by significant challenges, such as the high cost of some treatments, lack of insurance coverage, and the potential for adverse effects associated with some medications. To succeed in this competitive market, companies must focus on developing safe and effective treatments that are affordable and accessible to a broad range of patients.
The global Insomnia Treatment Market was valued at US$ 3,048.04 Mn in 2021 and is forecast to reach a value of US$ 4,752.2 Mn by 2028 at a CAGR of 6.6%between 2022 and 2028.
Leading Companies in the Insomnia Treatment Industry:
1. Merck & Co. Inc.
Merck & Co. Inc. is an American pharmaceutical company that was founded in 1891 and is headquartered in Kenilworth, New Jersey. It operates in more than 140 countries worldwide and is a leading producer of vaccines, oncology drugs, and cardiovascular medications. In November, 2021 Merck & Co. Inc. announced that the US Food and Drug Administration (FDA) had granted the company's investigational HIV-1 capsid inhibitor, MK-8718, Breakthrough Therapy designation for the treatment of people living with HIV-1 who have highly resistant strains of the virus.
2. Ebb Therapeutics
Ebb Therapeutics is a medical device company that was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania. The company focuses on developing innovative solutions to help people sleep better, such as its flagship product, the Ebb Insomnia Therapy.
3. Paratek Pharmaceuticals Inc.
Paratek Pharmaceuticals Inc. is a biopharmaceutical company that was founded in 1996 and is headquartered in Boston, Massachusetts. The company develops antibiotics to combat serious infections, such as skin infections, respiratory infections, and urinary tract infections. It operates in several countries worldwide, including the United States, Europe, and Australia.
4. Pfizer Inc.
Pfizer Inc. is an American multinational pharmaceutical company that was founded in 1849 and is headquartered in New York City. The company operates in more than 175 countries worldwide and produces a wide range of medicines and vaccines, including treatments for cancer, rare diseases, and infectious diseases like COVID-19. In March, 2023 Pfizer Inc. and BioNTech SE announced that the U.S. Food and Drug Administration (FDA) granted emergency use authorization (EUA) to provide a single booster dose of the companies’ Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine in children 6 months through 4 years of age (also referred to as under 5 years of age) at least 2 months after completion of primary vaccination with three doses of the Pfizer-BioNTech COVID-19 Original Vaccine.
5. Sanofi SA
Sanofi SA is a French multinational pharmaceutical company that was founded in 1973 and is headquartered in Paris. It operates in more than 100 countries worldwide and produces a wide range of medicines and vaccines, including treatments for diabetes, cancer, and rare diseases. In March, 2023 Sanofi and Provention Bio, Inc., a U.S.-based, publicly traded Biopharmaceutical Company focused on intercepting and preventing immune-mediated diseases including type 1 diabetes (T1D), have entered into an agreement under which Sanofi has agreed to acquire Provention Bio, Inc., for $25.00 per share in cash, representing an equity value of approximately $2.9 billion.
6. Electromedical Products International Inc.
Electromedical Products International Inc. is an American medical device company that was founded in 1964 and is headquartered in St. Paul, Minnesota. The company develops and manufactures respiratory therapy equipment and operates in several countries worldwide, including the United States, Canada, and Mexico.
7. Takeda Pharmaceutical Company Ltd
Takeda Pharmaceutical Company Ltd is a Japanese multinational pharmaceutical company that was founded in 1781 and is headquartered in Tokyo. It operates in more than 80 countries worldwide and produces a wide range of medicines and vaccines, including treatments for gastroenterology, oncology, and rare diseases. In September 2021, Takeda announced positive results from a Phase 3 trial of its oral plasma kallikrein inhibitor, TAK-994, for the treatment of hereditary angioedema (HAE).
8. Cerêve Inc.
Cerêve Inc. is an American medical device company that was founded in 2009 and is headquartered in Pittsburgh, Pennsylvania. The company develops and manufactures a non-drug, non-invasive sleep apnea treatment device and operates in several countries worldwide, including the United States and Canada.
*Definition-Insomnia treatment refers to the range of interventions used to manage and alleviate the symptoms of insomnia, a sleep disorder characterized by difficulty falling or staying asleep. Treatment options include medication, behavioral therapies, and lifestyle changes aimed at improving sleep hygiene.
